A study of pembrolizumab, cetuximab, and MK-1084 for patients with advanced or metastatic non-small cell lung cancer with KRAS G12C mutations
Recruiting
Investigated Diseases:Investigated Drugs:
Study of Revumenib, Cytarabine, and Fludarabine in Children with Relapsed or Refractory Acute Myeloid Leukemia
Recruiting
Investigated Diseases:Investigated Drugs:
+2
powered by
